Target Name: KPRP
NCBI ID: G448834
Review Report on KPRP Target / Biomarker Content of Review Report on KPRP Target / Biomarker
KPRP
Other Name(s): Keratinocyte expressed, proline-rich protein | Keratinocyte proline rich protein | keratinocyte proline rich protein | KPRP_HUMAN | keratinocyte expressed, proline-rich protein | C1orf45 | Keratinocyte proline-rich protein | hKPRP

KPRP: A Potential Drug Target and Biomarker

KPRP (Keratinocyte expressed, proline-rich protein) is a protein that is expressed in the Keratinocytes, which are the layers of skin that are responsible for producing and maintaining the skin's barrier. It is a 21-kDa protein that is composed of 195 amino acids, and it has been identified as a potential drug target and biomarker.

The skin is an essential organ that is responsible for protecting the body from external threats, such as harmful UV rays, pathogens, and environmental factors. The skin is also responsible for maintaining a stable pH and regulating the body's temperature. The Keratinocytes play a crucial role in the skin's barrier function, as they are responsible for producing the skin's layer of dead cells, known as the epidermis.

KPRP is a protein that is expressed in the Keratinocytes and is composed of 195 amino acids. It has been identified as a potential drug target and biomarker due to its unique structure and the role it plays in the skin's barrier function.

One of the key features of KPRP is its proline-rich region. Proline is a type of amino acid that is known for its ability to form a stable covalent bond with water, which can lead to increased protein stability and stability. The proline-rich region of KPRP is thought to be involved in its stability and function, as studies have shown that the presence of this region is critical for KPRP's ability to function in the skin.

In addition to its proline-rich region, KPRP has also been identified for its role in the skin's barrier function. The skin's barrier function is responsible for maintaining a stable pH and regulating the body's temperature. KPRP has been shown to play a crucial role in the regulation of the skin's barrier function, as studies have shown that it is involved in the production of the skin's layer of dead cells, known as the epidermis.

KPRP has also been shown to be involved in the regulation of the skin's immune response. The skin's immune response is important for protecting the body from external threats, such as harmful UV rays, pathogens, and environmental factors. Studies have shown that KPRP is involved in the regulation of the skin's immune response, as well as its barrier function.

Given its unique structure and its role in the skin's barrier function, KPRP is a protein that has potential as a drug target. Studies have shown that KPRP can be targeted by small molecules, such as inhibitors, which can be used to treat skin conditions, such as eczema and psoriasis. In addition, KPRP has also been shown to be involved in the regulation of the skin's immune response, which could make it a potential biomarker for the skin's immune function.

In conclusion, KPRP is a protein that is expressed in the Keratinocytes and has been identified as a potential drug target and biomarker. Its unique structure, as well as its role in the skin's barrier function and immune response, make it a promising target for future research and development. Further studies are needed to fully understand the potential of KPRP as a drug and biomarker.

Protein Name: Keratinocyte Proline Rich Protein

The "KPRP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KPRP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KPTN | KRAS | KRASP1 | KRBA1 | KRBA2 | KRBOX1 | KRBOX1-AS1 | KRBOX4 | KRBOX5 | KRCC1 | KREMEN1 | KREMEN2 | KRI1 | KRIT1 | KRR1 | KRT1 | KRT10 | KRT10-AS1 | KRT12 | KRT126P | KRT13 | KRT14 | KRT15 | KRT16 | KRT16P1 | KRT16P2 | KRT16P3 | KRT16P6 | KRT17 | KRT17P1 | KRT17P2 | KRT17P3 | KRT17P5 | KRT17P7 | KRT18 | KRT18P1 | KRT18P12 | KRT18P13 | KRT18P16 | KRT18P17 | KRT18P19 | KRT18P22 | KRT18P23 | KRT18P24 | KRT18P27 | KRT18P28 | KRT18P29 | KRT18P31 | KRT18P33 | KRT18P34 | KRT18P4 | KRT18P40 | KRT18P41 | KRT18P42 | KRT18P44 | KRT18P48 | KRT18P49 | KRT18P5 | KRT18P50 | KRT18P51 | KRT18P55 | KRT18P59 | KRT18P6 | KRT18P62 | KRT19 | KRT19P2 | KRT19P3 | KRT2 | KRT20 | KRT222 | KRT23 | KRT24 | KRT25 | KRT26 | KRT27 | KRT28 | KRT3 | KRT31 | KRT32 | KRT33A | KRT33B | KRT34 | KRT35 | KRT36 | KRT37 | KRT38 | KRT39 | KRT4 | KRT40 | KRT42P | KRT5 | KRT6A | KRT6B | KRT6C | KRT7 | KRT7-AS | KRT71 | KRT72 | KRT73 | KRT73-AS1